304 related articles for article (PubMed ID: 34075050)
1. Next generation of heart regenerative therapies: progress and promise of cardiac tissue engineering.
Tenreiro MF; Louro AF; Alves PM; Serra M
NPJ Regen Med; 2021 Jun; 6(1):30. PubMed ID: 34075050
[TBL] [Abstract][Full Text] [Related]
2. Advances in the design, generation, and application of tissue-engineered myocardial equivalents.
Bernava G; Iop L
Front Bioeng Biotechnol; 2023; 11():1247572. PubMed ID: 37811368
[TBL] [Abstract][Full Text] [Related]
3. Human Cardiac Tissue Engineering: From Pluripotent Stem Cells to Heart Repair.
Jackman CP; Shadrin IY; Carlson AL; Bursac N
Curr Opin Chem Eng; 2015 Feb; 7():57-64. PubMed ID: 25599018
[TBL] [Abstract][Full Text] [Related]
4. Combining Nanomaterials and Developmental Pathways to Design New Treatments for Cardiac Regeneration: The Pulsing Heart of Advanced Therapies.
Cassani M; Fernandes S; Vrbsky J; Ergir E; Cavalieri F; Forte G
Front Bioeng Biotechnol; 2020; 8():323. PubMed ID: 32391340
[TBL] [Abstract][Full Text] [Related]
5. Cells, Materials, and Fabrication Processes for Cardiac Tissue Engineering.
Montero P; Flandes-Iparraguirre M; Musquiz S; Pérez Araluce M; Plano D; Sanmartín C; Orive G; Gavira JJ; Prosper F; Mazo MM
Front Bioeng Biotechnol; 2020; 8():955. PubMed ID: 32850768
[TBL] [Abstract][Full Text] [Related]
6. Tissue engineering toward organ-specific regeneration and disease modeling.
Mandrycky C; Phong K; Zheng Y
MRS Commun; 2017 Sep; 7(3):332-347. PubMed ID: 29750131
[TBL] [Abstract][Full Text] [Related]
7. A Brief History in Cardiac Regeneration, and How the Extra Cellular Matrix May Turn the Tide.
van der Pol A; Bouten CVC
Front Cardiovasc Med; 2021; 8():682342. PubMed ID: 34095264
[TBL] [Abstract][Full Text] [Related]
8. Progress in cardiac research: from rebooting cardiac regeneration to a complete cell atlas of the heart.
Davidson SM; Padró T; Bollini S; Vilahur G; Duncker DJ; Evans PC; Guzik T; Hoefer IE; Waltenberger J; Wojta J; Weber C
Cardiovasc Res; 2021 Aug; 117(10):2161-2174. PubMed ID: 34114614
[TBL] [Abstract][Full Text] [Related]
9. Environmental factors influence somatic cell reprogramming to cardiomyocyte-like cells.
Van Handel B; Wang L; Ardehali R
Semin Cell Dev Biol; 2022 Feb; 122():44-49. PubMed ID: 34083115
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Physicochemical Characterization of Gelatine-Based Biodegradable Aerogel-like Composites as Possible Scaffolds for Regenerative Medicine.
Alfei S; Giordani P; Zuccari G
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732231
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of bone marrow mesenchymal stem cells into Leydig-like cells with testicular extract liquid in vitro.
Hua R; Liang FF; Gong FQ; Huang H; Xu YC; He M; Fang YH; Wei YS; Zhou WW; Mehmood A; Mo Y; Lin Z
In Vitro Cell Dev Biol Anim; 2024 May; ():. PubMed ID: 38698133
[TBL] [Abstract][Full Text] [Related]
12. Versatile human cardiac tissues engineered with perfusable heart extracellular microenvironment for biomedical applications.
Min S; Kim S; Sim WS; Choi YS; Joo H; Park JH; Lee SJ; Kim H; Lee MJ; Jeong I; Cui B; Jo SH; Kim JJ; Hong SB; Choi YJ; Ban K; Kim YG; Park JU; Lee HA; Park HJ; Cho SW
Nat Commun; 2024 Mar; 15(1):2564. PubMed ID: 38519491
[TBL] [Abstract][Full Text] [Related]
13. Advances in 3D Bioprinted Cardiac Tissue Using Stem Cell-Derived Cardiomyocytes.
Bliley JM; Stang MA; Behre A; Feinberg AW
Stem Cells Transl Med; 2024 May; 13(5):425-435. PubMed ID: 38502194
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Characterization of Amine and Aldehyde-Containing Copolymers for Enzymatic Crosslinking of Gelatine.
Alfei S; Pintaudi F; Zuccari G
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474144
[TBL] [Abstract][Full Text] [Related]
15. Mechanical properties of the rabbit and human decellularized patches for well-tolerated/reinforced organ in cardiac tissue engineering.
Mousavi Khatat M; Same S; Moharamzadeh K; Soleimani Rad J; Mehdipour A; Roshangar L
J Cardiovasc Thorac Res; 2023; 15(4):244-249. PubMed ID: 38357560
[TBL] [Abstract][Full Text] [Related]
16. Advances in the Generation of Constructed Cardiac Tissue Derived from Induced Pluripotent Stem Cells for Disease Modeling and Therapeutic Discovery.
Roland TJ; Song K
Cells; 2024 Jan; 13(3):. PubMed ID: 38334642
[TBL] [Abstract][Full Text] [Related]
17. Partial Decellularization as a Method to Improve the Biocompatibility of Heart Tissue Implants.
Meșină M; Mîndrilă I; Meșină-Botoran MI; Mîndrilă LA; Pirici I
Curr Health Sci J; 2023; 49(3):351-361. PubMed ID: 38314222
[TBL] [Abstract][Full Text] [Related]
18. Construction of millimeter-scale vascularized engineered myocardial tissue using a mixed gel.
Ke M; Xu W; Hao Y; Zheng F; Yang G; Fan Y; Wang F; Nie Z; Zhu C
Regen Biomater; 2024; 11():rbad117. PubMed ID: 38223293
[TBL] [Abstract][Full Text] [Related]
19. Endothelial cell dysfunction in cardiac disease: driver or consequence?
Allbritton-King JD; García-Cardeña G
Front Cell Dev Biol; 2023; 11():1278166. PubMed ID: 37965580
[TBL] [Abstract][Full Text] [Related]
20. Targeting the redox system for cardiovascular regeneration in aging.
Allemann MS; Lee P; Beer JH; Saeedi Saravi SS
Aging Cell; 2023 Dec; 22(12):e14020. PubMed ID: 37957823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
